By Paul Schmitt
A bill that will allow terminally ill Americans to try experimental therapies and drugs is close to becoming law. After months of deliberation and bouncing back and forth from the House of Representatives and the U.S Senate, the “Right-To-Try” bill was approved late Tuesday by the house. The legislation was approved by the House by a 250-169 margin. U.S. Senator Ron Johnson, who co-sponsored the bill, says that the patients and families who fought for the bill on a state level deserve the credit.
The Right-to-Try bill will now go to President Donald Trump’s desk for signing. Johnson stated earlier this month that the President had previously promised to sign the Senate’s version of the bill. Critics of the bill argue that the law would lessen the Federal Drug Administration’s power and not make it easier for terminally ill people to access drugs.